Summary of testimony by Cheryl DeMars, President and CEO, The Alliance before the Senate Committee on Health, Education, Labor and Pensions Hearing on Nov. 28, 2018.
A recent Google search for “opioid crisis” produced 90 million results, an indication that America’s addiction to opioids has gained serious media attention over the last several years.
Two bills designed to promote transparency in the sale of prescription drugs by banning pharmacy “gag clauses” were passed by Congress and signed into law by the President this month.
American Patients First, the Trump Administration’s “blueprint to lower drug prices,” contains provisions with the potential for a significant impact on the health care marketplace, according to Alex Jung, managing director in the Parthenon-EY practice of Ernst & Young LLP.
Onsite clinics are a growing trend for American employers. Today, 50 percent of employers with over 5,000 employees have onsite or near-site clinics, according to the National Association of Worksite Health Clinics. It’s predicted that in the next two years, this percentage will grow to two out of three.
Although we are in the relatively “quiet time” between partisan primaries and the November general election, we need your vote one more time to approve new Health Policy Resolutions for The Alliance. We promise no TV ads – just some emails and this brief blog post.